Wyndham H. Wilson

Wyndham H. Wilson

Auto-generated profile, based on publicly available information

Wyndham H. Wilson

Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2020 in Science Immunology
Verified
Journal Article
Open access
PDF file
MRMark Roschewski
Mark Roschewski
MLMichail S. Lionakis
Michail S. Lionakis
JSJeff P. Sharman
Jeff P. Sharman
JRJoseph Roswarski
Joseph Roswarski
AGAndre Goy
Andre Goy
WWWyndham H. Wilson
Wyndham H. Wilson
Acalabrutinib targets activated BTK in macrophages and was associated with reduced inflammation and clinical improvement in COVID-19.

31 March 2023 in The Lancet Haematology
Verified
Journal Article
Closed access
CMChristopher Melani
Christopher Melani
KDKennichi Dowdell
Kennichi Dowdell
SPStefania Pittaluga
Stefania Pittaluga
KDKieron Dunleavy
Kieron Dunleavy
MRMark Roschewski
Mark Roschewski
WWWyndham H Wilson
Wyndham H Wilson